Diakonhjemmet Sykehus AS — Sponsor Intelligence | 5 EU Trials

Filter these 5 trials by condition, phase, country and more.

5 Registered trials

2 Recruiting

3 Completed trials

6 Countries active

6 Unique IMPs

100% Results reported

Phase IV

100%

3 of 3 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

Top indications

5 total

MethMax trial Recruiting

2023-507714-27-00 Phase IV 6 countries METHOTREXATE
Painful Inflammatory Carpometacarpal-1 osteoArthritis treated with intraarticular Steroids, Saline or an Occupational therapy intervention: … Recruiting

2023-505254-17-00 Phase IV 1 country SODIUM CHLORIDE; TRIAMCINOLONE ACETONIDE
Effect of proactive therapeutic drug monitoring on maintenance of sustained disease control in adults with rheumatoid arthritis on a subcuta… Ended

2023-510184-35-00 Phase IV 5 countries ADALIMUMAB
The MERINO trial Ended

2023-510523-30-00 Phase IV 1 country METHOTREXATE
NOR-CACTUS Ended

2024-511223-34-00 Phase IV 1 country TRIAMCINOLONE ACETONIDE; TRIAMCINOLONE HEXACETONIDE

Showing 1–5 of 5 trials